Open AccessPhase II Studies in Soft Tissue Sarcoma: Time for Reappraisal
Author(s) -
Sleijfer Stefan
Publication year - 2012
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1634/theoncologist.2011-0382
Subject(s) - medicine , sorafenib , angiosarcoma , soft tissue sarcoma , sarcoma , oncology , phases of clinical research , clinical trial , surgery , pathology , hepatocellular carcinoma
A phase II study with sorafenib in patients with angiosarcoma conducted by the French Sarcoma Group, and published in this issue of The Oncologist , is evaluated. The importance of proper design and conduct of phase II trials is stressed.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom